Niue Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Niue Health Report.

Press releases published on June 4, 2026

Orange Plan Management Celebrates 4.9-Star Review Milestone, Reinforcing Its Role as a Leading NDIS Plan Manager in Australia
NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option
DLH Announces Filing of New Shelf Registration Statement
Cloudbreak Pharma Announces Final Patient Visit for 12-Month Efficacy Endpoint in Phase 3 Study of CBT-001 as a Potential Treatment for Pterygium
Park Dental Partners Expands Presence in Rochester, Minn., with Addition of Zumbro View Dental
Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors
Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific Sessions
TOMI Expands European Footprint with New Regulatory Approvals for Binary Ionization Technology
GILEAD SCIENCES AND LAKEFRONT COMPLETE ACQUISITION OF OURO MEDICINES TO FURTHER EXPAND INFLAMMATION PIPELINE
GILEAD SCIENCES EN LAKEFRONT RONDEN DE OVERNAME VAN OURO MEDICINES AF OM DE PIJPLIJN OP HET GEBIED VAN ONTSTEKINGEN VERDER UIT TE BREIDEN
CooperCompanies Announces Second Quarter 2026 Results
BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD. 
SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026
Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Lyell Immunopharma to Present Phase 1/2 Safety and Translational Data for Ronde-Cel in Large B-Cell Lymphoma at the European Hematology Association 2026 Congress
Nyxoah Announces Proposed Offering of Ordinary Shares
Nyxoah Annonce une Proposition d'Offre d'Actions Ordinaires
Nyxoah Enters New Chapter of Long Term Value Creation
Nyxoah Entre dans une Nouvelle Phase de Création de Valeur à Long Terme

Share this page:

Sign up for:

Niue Health Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.